Metafines

Developer of anticancer drugs using cancer metabolism

placeSeongnam, Gyeonggi-do, South Korea calendar_todayFounded 2021 groups15 employees language metafines.com

Innovation

4 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 38 times.

YearFilings
20191
20201
20211
20221
20231
20243
20251

Investor mix

11 investors on record; lead investors include DSC Investment, BM Korea, Korea Investment Value Asset Management, Prodigy Investment.

Investor typeCountShare
Venture capital436%
Private equity19%
Other / undisclosed655%
Coming soon